Literature DB >> 7550395

Nucleolar organizer regions in low- and high-grade carcinomas of the prostate.

B Helpap1, C Riede.   

Abstract

The number of silver-stained nucleolar organizer regions (AgNORs) and the status of nucleoli were studied in biopsies from 10 cases of normoglandular prostatic tissue and the findings were compared with the results obtained for 10 cases of hyperplastic prostatic tissue (BPH) and 74 cases of prostatic carcinoma of various grades of malignancy. There was an increase in the number of AgNORs detected between the grade of malignancy found in highly versus poorly differentiated carcinomas of the prostate. Furthermore AgNOR values differed significantly among the groups compared (P < 0.001). The nucleolar status confirmed these differences. In addition, the significantly different survival of patients suffering from prostatic carcinomas support our idea of subdividing GII carcinomas into group IIa (low risk) and group IIb (high risk). This subgrading implies the possibility of preoperatively identifying patients with a prostate carcinoma of high malignancy within the GII carcinoma group.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7550395     DOI: 10.1007/bf00184879

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  33 in total

1.  Stereological estimation of nucleolar organizer regions in prostatic tissue with an optical disector.

Authors:  A B Hansen; C B Andersen
Journal:  APMIS       Date:  1992-02       Impact factor: 3.205

2.  Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level.

Authors:  D Ploton; M Menager; P Jeannesson; G Himber; F Pigeon; J J Adnet
Journal:  Histochem J       Date:  1986-01

Review 3.  Nucleolar organiser regions.

Authors:  J Crocker
Journal:  Curr Top Pathol       Date:  1990

4.  Nucleolar prominence as a diagnostic variable in prostatic carcinoma.

Authors:  P R Kelemen; R J Buschmann; P Weisz-Carrington
Journal:  Cancer       Date:  1990-02-15       Impact factor: 6.860

Review 5.  Consensus review of the clinical utility of DNA content cytometry in prostate cancer.

Authors:  T V Shankey; O P Kallioniemi; J M Koslowski; M L Lieber; B H Mayall; G Miller; G J Smith
Journal:  Cytometry       Date:  1993

6.  Nucleoli in low-grade prostate adenocarcinoma and adenosis.

Authors:  C E Kramer; J I Epstein
Journal:  Hum Pathol       Date:  1993-06       Impact factor: 3.466

7.  Nucleolar organizer regions in prostate cancer.

Authors:  S Kobayashi; M Kuriyama; N Yamamoto; Y Takahashi; I Shinoda; T Takeuchi; T Deguchi; Y Kawada
Journal:  Adv Exp Med Biol       Date:  1992       Impact factor: 2.622

8.  Nucleolar organizer regions in prostatic adenocarcinomas. Comparison with flow cytometric analysis, tumor grade, stage and serum prostate-specific antigen levels.

Authors:  G Alivizatos; K Pavlaki; A Giannopoulos; D Mitropoulos; A Tsega; C Deliveliotis; C Dimopoulos
Journal:  Eur Urol       Date:  1992       Impact factor: 20.096

9.  Prostatic invasive adenocarcinoma. Effect of combination endocrine therapy (LHRH agonist and flutamide) on the expression and location of proliferating cell nuclear antigen (PCNA).

Authors:  C Magi Galluzzi; R Montironi; I Giannulis; L Diamanti; M Scarpelli; G Muzzonigro; M Polito
Journal:  Pathol Res Pract       Date:  1993-12       Impact factor: 3.250

10.  Observations on the number, size and localization of nucleoli in hyperplastic and neoplastic prostatic disease.

Authors:  B Helpap
Journal:  Histopathology       Date:  1988-08       Impact factor: 5.087

View more
  2 in total

Review 1.  The significance of atypical adenomatous hyperplasia and prostatic intraepithelial neoplasia for the development of prostate carcinoma. An update.

Authors:  B G Helpap; D G Bostwick; R Montironi
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

Review 2.  [Prostate cancer. Part 1: Review of cell kinetics over the years 1966-2015 and future perspectives of the new grading of the International Society of Urological Pathology (ISUP)].

Authors:  B Helpap; L Bubendorf
Journal:  Pathologe       Date:  2016-02       Impact factor: 1.011

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.